Category: .

EHI recently conducted a hands-on training session for a new user on measuring glucose-6-phosphate dehydrogenase (G6PD) activity using the SD Biosensor G6PD Analyzer medical device. This training is part of EHI’s ongoing commitment to strengthening diagnostic capacity and raising awareness of G6PD deficiency, a common genetic condition that can have significant implications for patient care,… Continue reading EHI Strengthening Diagnostic Capacity in G6PD Activity Measurement

EHI successfully implemented a Virology MasterClass from 6 January to 10 February 2026 as part of its ongoing commitment to capacity building in health research. Delivered in a hybrid format (in-person and via Zoom), the program provided EHI research staff with an opportunity to strengthen their foundational knowledge in virology. The sessions were led by… Continue reading EHI Conducts Exclusive Virology MasterClass for Research Staff

On 30 January 2026, EHI hosted an audience and discussion session with the head of the National Research and Innovation Agency (BRIN) as part of an effort to strengthen EHI’s collaboration network within the national research and innovation ecosystem. This meeting acts as an opportunity for EHI and BRIN to bring forward issues, share perspectives,… Continue reading EHI Strengthening Collaboration Dialogues in the National Research and Innovation Ecosystem

EHI recently commenced an internal workshop focused on utilizing the Cytiva NanoAssemblr™ Ignite system to generate messenger RNA lipid nanoparticles (mRNA-LNPs) for vaccine development. The workshop was conducted at the EHI laboratory and supported by Cytiva and PT Fluida Teknika. EHI believes that a strong collaboration between research and industry partners is necessary to advance… Continue reading EHI Participates in NanoAssemblr™ Ignite Training to Strengthen mRNA Vaccine Development Capacity

On 26 November 2025, EHI held a constructive meeting with the Embassy of the Republic of Indonesia in Nairobi (KBRI Nairobi) to explore potential collaboration in vaccine development and the expansion of Indonesian vaccine access in African markets, with a particular focus on Kenya. For EHI, this engagement marks an important step toward aligning Indonesia’s… Continue reading EHI Explores Vaccine Collaboration with KBRI Nairobi to Strengthen Global Health